Table 2 (abstract O16). See text for description
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
|  | Arm 1 n = 31 | Arm 2 n = 32 | Arm 3 n = 29 | 3 vs 1 p OR (CI) | 2 vs 1 p OR (CI) | 3 vs 2 p OR (CI) |
|---|---|---|---|---|---|---|
ACRPEdi30(%)(CI) | 92.2 (82,1-102.4) | 84.4 (71.2-97.5) | 96.6 (89.8-103.3) | 0.1 1.7 (0.8-3.4) | 0.8 0.9(0.5-1.7) | 0.1 0.9-3.7 |
ACRPedi50 (%)(CI) | 85.5 (72.4-98.6) | 83.8 (70.1-97.4) | 93.1 (83.7-102.4) | 0.3 1.4(0.7-2.8) | 0.9 1.1(0.6-2.0) | 0.4 1.3(0.7-2.7) |
ACRPedi70 (%)(CI) | 69.0 (52.1-85.9) | 68.8 (51.6-85.9) | 82.8 (68.8-96.8) | 0.07 1.8(1.0-3.3) | 0.7 0.9(0.4-1.7) | 0.03 2.1(1.1-4.0) |
Inactive disease (%) | 61.0 (39.7-82.3) | 63.1 (43.6-82.7) | 61.0 (40.9-81.2) | 0.9 1.0(0.7-1.7) | 0.1 0.7(0.4-1.1) | 0.09 1.5(0.9-2.5) |
JADAS-10 (CI) | 2.6(1.4-3.8) | 4.0(2.2-5.8) | 3.0(1.6-4.4) | 0.6 0.6(0.1-3.5) | 0.2 3.1(0.5-20.3) | 0.09 0.2(0.03-1.3) |